Chronic Pain Clinical Trial
Official title:
ReActivate: Physiotherapist Led Intervention for Adolescents With Pain and Psychological Distress. A Sequential Replicated and Randomized Single Case Experimental Design (SCED).
Recurrent or persistent pain and psychological distress are alarmingly common problems among adolescents, in Sweden as well as globally. They often co-occur and have been shown to be predictors of sustained problems in adulthood. Adequate treatment early on in the development of problems has been shown important in order to decrease the risk of sustained problems in adulthood but available treatments have only modest effects. There is thus a need for treatment development, not in the least for (secondary) preventative purposes. The aim of this project is therefore to develop an evidence based and cost-effective secondary preventative intervention. Specifically, this project aims to develop and test a physiotherapist led treatment for adolescents with recurrent or persistent pain and psychological distress based upon graded exposure to physical activity and reactivation.
Status | Recruiting |
Enrollment | 35 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 19 Years |
Eligibility | Inclusion Criteria: - Age 12-19 - Psychological distress, such as anxiety, depressive symptoms or stress, =2 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent) - Persistent (consistently or weekly recurrent) musculoskeletal pain problems for =3 months, with pain intensity =2 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent) - Presence of avoidance behaviour and/or or worry about symptoms/problems, =1 on a numeric rating scale 0-6 (0=not at all, 6=to a great extent); > 50 on at least one activity of the PHODA. - Swedish speaking and able to fill out questionnaires Exclusion Criteria: - Serious/malignant disease - Participation in other rehabilitation program - Severe mental health problems - Substance abuse - Severe learning disabilities |
Country | Name | City | State |
---|---|---|---|
Sweden | Region Örebro county | Örebro |
Lead Sponsor | Collaborator |
---|---|
Örebro University, Sweden | Region Örebro County |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Treatment Inventory of Costs in Patients with psychiatric disorders (Tic-P), medical resources | Change in use of medical resources. Dichotomous scale completed by open ended answers if answer is yes. | baseline, 12 weeks, 6 months after terminated intervention | |
Other | Treatment Inventory of Costs in Patients with psychiatric disorders (Tic-P), school absence | Change in school abcense. Dichotomous scale completed by open ended answers if answer is yes. One question is completed by one question with Numerical Rating Scale 1-10 (higher values, worse outcome) if answer is yes. | baseline, 12 weeks, 6 months after terminated intervention | |
Other | Accelerometer | Change in physical activity, digital device counting steps | 7 days of the first week of baseline (randomly assigned to be 7, 14 or 21 days). 7 days assessment 6 months after terminated assessment. | |
Primary | Activity engagement change | Change in self-rated activity engagement. Numerical Rating Scale, range 0-6 (1 question: lower values, worse outcome, 1 question: Lower values, better outcome ) | repeated daily through phase A (randomly assigned to be 7, 14 or 21 days) and treatment phase B (9-11 weeks). Total time frame of assessment is 12 weeks (84 days). 7 days assessment 6 months after terminated intervention | |
Primary | Symptom distress change | Change in self-rated distress about symptoms. Numerical Rating Scale, range 0-6 (3 questions, higher values, worse outcome) | repeated daily through phase A (randomly assigned to be 7, 14 or 21 days) and treatment phase B (9-11 weeks). Total time frame of assessment is 12 weeks (84 days). 7 days assessment 6 months after terminated intervention. | |
Secondary | Functional Disability Inventory (FDI) change | Change in functional disability. Descriptive Rating Scale, range 0-64 (higher values, worse outcome) | baseline, after treatment phase B (12 weeks), 6 months after terminated intervention | |
Secondary | Center of Epidemiological Studies Depression Scales for Children (CES-DC) change | Change in depressive symptoms. Descriptive Rating Scale, range 0-60 (higher values, worse outcome) | baseline, after treatment phase B (12 weeks), 6 months after terminated intervention | |
Secondary | The Pediatric Quality of Life Acute version (PedsQL) PedsQLâ„¢ | Change in quality of life. Descriptive Rating Scale, range 0-92 (higher values, worse outcome) | baseline, after treatment phase B (12 weeks), 6 months after terminated intervention | |
Secondary | Change in psychological distress | Change in self-related symptoms of psychological distress. Numerical Rating Scale, range 0-6 (3 questions, higher values, worse outcome) | repeated daily through phase A (randomly assigned to be 7, 14 or 21 days) and treatment phase B (9-11 weeks). Total time frame of assessment is 12 weeks (84days). 7 days assessment 6 months after terminated assessment. | |
Secondary | Pain change | Change in self-related pain symptoms. Numerical Rating Scale range 0-6 (higher values, worse outcome) | repeated daily through phase A (randomly assigned to be 7, 14 or 21 days) and treatment phase B (9-11 weeks). Total time frame of assessment is 12 weeks (84days). 7 days assessment 6 months after terminated assessment. | |
Secondary | Fear of Pain Questionnaire Children Short-form (FOPQ-C SF) change | Change in fear of pain. Descriptiv Rating Scale, range 0-40 (higher values worse outcome) | baseline, after treatment phase B (12 weeks), 6 months after terminated intervention | |
Secondary | The Photograph Series of Daily Activities for youth (PHODA) change - short | Change in percieved harmfulness. Photographs with 50 activities, rated on a Subjective Self-rating Scale, range 0-100mm/item (higher values, worse outcome) | First session after baseline (randomly assigned to be 7, 14 or 21 days), after treatment phase B (12 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|